In Vitro Fertilization Device Market Global Report 2026

The in vitro fertilization device market size has grown strongly in recent years. It will grow from $20.44 billion in 2025 to $22.32 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to rising infertility prevalence, expansion of fertility clinics globally, improvement in ivf success rates over time, introduction of basic embryo culture and lab systems, increasing awareness of assisted reproductive technologies.

The in vitro fertilization device market size is expected to see strong growth in the next few years. It will grow to $31.23 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to rising delayed parenthood trends, increasing government reimbursement and insurance coverage, expansion of fertility tourism across regions, growing demand in emerging economies, increasing adoption of cryopreservation for fertility preservation. Major trends in the forecast period include single embryo transfer adoption and elective single embryo transfer protocols, expanded fertility preservation demand and social egg freezing adoption, rising ivf treatment affordability and insurance coverage expansion, standardization of lab quality control and contamination prevention protocols, increasing demand for portable and modular ivf lab setups in emerging markets.

The increasing rates of infertility among couples are expected to accelerate the growth of the in vitro fertilization device market in the coming years. Infertility among couples refers to the inability to achieve pregnancy after a defined period of regular, unprotected sexual activity. The growing prevalence of infertility is driven by factors such as delayed parenthood, as more individuals are choosing to start families at older ages when natural fertility levels decline. In vitro fertilization devices assist couples facing infertility by providing advanced laboratory instruments and precise technological systems that enhance fertilization procedures, support embryo development, and improve the overall efficiency of assisted reproductive treatments. For example, in August 2025, according to the Office for National Statistics (ONS), a UK government department, the total fertility rate (TFR) in England and Wales remained at a record low of 1.41 children per woman in 2024, compared with 1.42 in 2023, indicating the continued decline in fertility rates and the increasing challenges associated with infertility. Therefore, the rising infertility rates among couples are supporting the growth of the in vitro fertilization device market.

Leading companies operating in the in vitro fertilization device market are focusing on developing advanced products such as embryo and oocyte vitrification and storage devices to enhance cryopreservation efficiency, improve embryo viability, and increase the success rates of assisted reproductive procedures. Embryo and oocyte vitrification and storage devices are specialized IVF systems that rapidly freeze and securely preserve embryos and eggs, maintaining their viability and quality for future fertility treatments. For example, in October 2024, Cook Medical, a US-based medical device company, launched the NestVT, a vitrification and storage device for embryos and oocytes. It improves the safe vitrification, cryo-storage, and handling of embryos and oocytes during IVF procedures, enhancing specimen stability and supporting efficient fertility treatment workflows. The NestVT vitrification device features a fully enclosed design that helps prevent oocytes and embryos from coming into direct contact with liquid nitrogen during cryopreservation.

In October 2023, Hamilton Thorne Ltd., a US-based manufacturer of medical equipment, acquired Gynetics Medical Products N.V. and Gynetics Services B.V. for an undisclosed amount. Through this acquisition, Hamilton Thorne aimed to enhance its IVF consumables portfolio, strengthen its footprint in the European assisted reproductive technology (ART) market, and broaden its range of embryo transfer catheters, ovum pick-up needles, and other IVF laboratory and clinical products. Gynetics Medical Products N.V. is a Belgium-based producer of advanced in vitro fertilization (IVF) devices and consumables supplied to fertility clinics across the globe.

Major companies operating in the in vitro fertilization device market report are ASB Medical System, Carl Zeiss AG, CooperSurgical Inc., Cryologic Pty Ltd., Esco Medical, Eppendorf SE, FertiPro N.V., IVFsynergy Ltd., Kitazato Corporation, LEEC Limited, MedGyn Products Inc., Merck KGaA, Minitube International AG, Narishige Co. Ltd., Nikon Instruments Inc., NidaCon International AB, Planer Ltd., RI.MOS. S.r.l., Sperm Processor Pvt. Ltd., The Baker Company Inc., Thermo Fisher Scientific, Vitrolife AB, Vitromed Healthcare.

North America was the dominating region in the in vitro fertilization device market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the in vitro fertilization device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in vitro fertilization device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.